MedTrace Logo

Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

NCT00935805 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2011-10-26

No results posted yet for this study

Summary

The aim of this study is to to analyze if it is possible to reach the goals of HbA1c \<7.0% and blood pressure \<= 130/80 mm Hg in a cohort of patients with type 2 diabetes attending a primary care unit, using ony those resources available at the unit, and provided by the Brazilian National Health System. It is an open label, observational study, with a duration of 4-6 years. Patients attending a primary care outpatient facility will be sequentially included in the study provided they give consent. They will be followed on a monthly basis by a team of physicians and nurses. Glucose, A1c, Blood PRessure will be the outcomes.

Conditions

Interventions

DRUG

Metformin

850 mg TID

DRUG

Glybenclamide

10 mg BID

DRUG

NPH insulin

Variable SC dose

DRUG

Hydrochlorothiazide

25 mg QD introduced as initial therapy for hypertension

DRUG

Propranolol

40 mg BID

DRUG

Captopril

50 mg TID

DRUG

Amlodipine

10 mg QD

Sponsors & Collaborators

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    collaborator OTHER_GOV

  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil

    collaborator OTHER

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Rogerio Friedman, MD, PhD · Hospital de Clinicas de Porto Alegre

  • Jorge L Gross, MD, PhD · Hospital de Clinicas de Porto Alegre

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2012-01-31
Completion
2012-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00935805 on ClinicalTrials.gov